Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial.

Neoptolemos JP, Moore MJ, Cox TF, Valle JW, Palmer DH, McDonald AC, Carter R, Tebbutt NC, Dervenis C, Smith D, Glimelius B, Charnley RM, Lacaine F, Scarfe AG, Middleton MR, Anthoney A, Ghaneh P, Halloran CM, Lerch MM, Oláh A, Rawcliffe CL, Verbeke CS, Campbell F, Büchler MW; European Study Group for Pancreatic Cancer.

JAMA. 2012 Jul 11;308(2):147-56. doi: 10.1001/jama.2012.7352. Erratum in: JAMA. 2012 Nov 14;308(18):1861.

PMID:
22782416
2.

Neoadjuvant and adjuvant strategies for pancreatic cancer.

Ghaneh P, Smith R, Tudor-Smith C, Raraty M, Neoptolemos JP.

Eur J Surg Oncol. 2008 Mar;34(3):297-305. Epub 2007 Oct 22. Review.

PMID:
17936564
3.

Meta-analysis of adjuvant therapy following curative surgery for periampullary adenocarcinoma.

Acharya A, Markar SR, Sodergren MH, Malietzis G, Darzi A, Athanasiou T, Khan AZ.

Br J Surg. 2017 Jun;104(7):814-822. doi: 10.1002/bjs.10563. Review.

PMID:
28518410
4.

Adenocarcinoma of the ampulla of Vater: what treatment options are available?

Senatore FJ, Ynson ML, Dasanu CA.

J Oncol Pharm Pract. 2015 Oct;21(5):364-9. doi: 10.1177/1078155214538086. Epub 2014 Jun 5. Review.

PMID:
24906539
5.

A systematic overview of chemotherapy effects in colorectal cancer.

Ragnhammar P, Hafström L, Nygren P, Glimelius B; SBU-group. Swedish Council of Technology Assessment in Health Care.

Acta Oncol. 2001;40(2-3):282-308. Review.

PMID:
11441937
6.

Updated therapeutic outcome for patients with periampullary and pancreatic cancer related to recent translational research.

Buanes TA.

World J Gastroenterol. 2016 Dec 28;22(48):10502-10511. doi: 10.3748/wjg.v22.i48.10502. Review.

PMID:
28082802
7.

Adjuvant therapy in pancreatic cancer: a critical appraisal.

Oettle H, Neuhaus P.

Drugs. 2007;67(16):2293-310. Review.

PMID:
17983252
8.

ESPAC-1 trial progress report: the European randomized adjuvant study comparing radiochemotherapy, 6 months chemotherapy and combination therapy versus observation in pancreatic cancer.

Neoptolemos JP, Kerr DJ, Beger H, Link K, Pederzoli P, Bassi C, Dervenis C, Fernandez-Cruz L, Laçaine F, Friess H, Büchler M.

Digestion. 1997;58(6):570-7. Review.

PMID:
9438604
9.

Postoperative radiotherapy in periampullary cancers: a brief review.

Bahl A, Bhattacharyya T, Kapoor R, Singh OA, Parsee T, Sharma SC.

J Gastrointest Cancer. 2013 Mar;44(1):111-4. doi: 10.1007/s12029-012-9421-2. Review.

PMID:
22843209
10.

Adjuvant treatment for pancreatic ductal carcinoma.

Macarulla T, Fernández T, Gallardo ME, Hernando O, López AM, Hidalgo M.

Clin Transl Oncol. 2017 Oct;19(10):1199-1204. doi: 10.1007/s12094-017-1683-5. Epub 2017 Jun 21. Review.

PMID:
28639051
11.

Adjuvant pharmacotherapy in the management of elderly patients with pancreatic cancer.

Maréchal R, Demols A, Van Laethem JL.

Drugs Aging. 2013 Mar;30(3):155-65. doi: 10.1007/s40266-013-0049-0. Review.

PMID:
23338795
12.

Ampullary cancer of intestinal origin and duodenal cancer - A logical clinical and therapeutic subgroup in periampullary cancer.

Chandrasegaram MD, Gill AJ, Samra J, Price T, Chen J, Fawcett J, Merrett ND.

World J Gastrointest Oncol. 2017 Oct 15;9(10):407-415. doi: 10.4251/wjgo.v9.i10.407. Review.

PMID:
29085567
13.

Adjuvant chemotherapy in pancreatic cancer.

Bramhall SR, Neoptolemos JP.

Int J Pancreatol. 1997 Feb;21(1):59-63. Review.

PMID:
9127175
14.

Strength of the evidence: adjuvant therapy for resected pancreatic cancer.

Picozzi VJ, Pisters PW, Vickers SM, Strasberg SM.

J Gastrointest Surg. 2008 Apr;12(4):657-61. Epub 2007 Dec 22. Review.

PMID:
18157582
15.

Neoadjuvant, adjuvant, and palliative treatment of pancreatic cancer.

Birk D, Beger HG.

Curr Gastroenterol Rep. 2001 Apr;3(2):129-35. Review.

PMID:
11276380
16.

Pancreaticoduodenectomy for periampullary tumours: a review article based on Surveillance, End Results and Epidemiology (SEER) database.

Kamarajah SK.

Clin Transl Oncol. 2018 Jan 15. doi: 10.1007/s12094-018-1832-5. [Epub ahead of print] Review.

PMID:
29335829
17.

Novel adjuvant therapies for pancreatic adenocarcinoma.

Oyasiji T, Ma WW.

J Gastrointest Oncol. 2015 Aug;6(4):430-5. doi: 10.3978/j.issn.2078-6891.2015.031. Review.

PMID:
26261729
18.

Randomized Clinical Trials in Pancreatic Cancer.

Goel N, Reddy SS.

Surg Oncol Clin N Am. 2017 Oct;26(4):767-790. doi: 10.1016/j.soc.2017.05.005. Epub 2017 Aug 4. Review.

PMID:
28923230
19.

Duodenal adenocarcinoma: Advances in diagnosis and surgical management.

Cloyd JM, George E, Visser BC.

World J Gastrointest Surg. 2016 Mar 27;8(3):212-21. doi: 10.4240/wjgs.v8.i3.212. Review.

PMID:
27022448
20.

Ploidy and DNA index as prognostic factors in resected pancreatic ductal adenocarcinoma - a review of the literature.

Durlik M, Tuchalska-Czuroń J.

Prz Gastroenterol. 2014;9(6):313-6. doi: 10.5114/pg.2014.47892. Epub 2014 Dec 30. Review.

PMID:
25653724

Supplemental Content

Support Center